Showing results (101-110 of 184) with videos related to
Sort By:
Pageof 19
Life Sciences|March 8, 1982
Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's diseaseJ H Growdon, E Melamed, M Logue, et al.Neurology|February 1, 1986
CSF somatostatin-like immunoreactivity in dementiaM F Beal, J H Growdon, M F Mazurek, et al.Life Sciences|August 5, 1985
Differential effects of DSP-4 administration on regional brain norepinephrine turnover in ratsM P Logue, J H Growdon, I L Coviella, et al.Brain : a Journal of Neurology|June 1, 1990
Recency and frequency discrimination in the amnesic patient H.MH J Sagar, J D Gabrieli, E V Sullivan, et al.Journal of Neuropathology and Experimental Neurology|November 24, 1999
Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer diseaseK L Newell, B T Hyman, J H Growdon, et al.Neuro-Degenerative Diseases|October 16, 2007
Plasma F2A isoprostane levels in Alzheimer's and Parkinson's diseaseM C Irizarry, Y Yao, B T Hyman, et al.Human Brain Mapping|April 22, 2010
Time series analysis in the time domain and resampling methods for studies of functional magnetic resonance brain imagingJ J Locascio, P J Jennings, C I Moore, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1989
Penetrating head injury in young adulthood exacerbates cognitive decline in later yearsS Corkin, T J Rosen, E V Sullivan, et al.Neurology|March 1, 1992
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's diseaseP V Arriagada, J H Growdon, E T Hedley-Whyte, et al.Neurology|May 22, 1998
Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study GroupJ H Growdon, K Kieburtz, M P McDermott, et al.Pageof 19